Magnus Financial Group’s Medicines Co MDCO Stock Holding History

Magnus Financial Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,968	Closed	-$248K	–	638
2019 Q3	$248K	Buy	+4,968	New	+$198K	0.05%	350

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Magnus Financial Group's MDCO Position: Q4 2019 in Review

Magnus Financial Group sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 4,968 shares — an estimated $248K sold.

Magnus Financial Group first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $248K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Magnus Financial Group reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Magnus Financial Group sold 4,968 Medicines Co shares in Q4 2019, an estimated $248K.
Magnus Financial Group first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
Magnus Financial Group's Medicines Co position peaked at $248K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Magnus Financial Group's 13F filing for Q4 2019, filed 28 Jan 2020.